Novo Nordisk
NVO
#19
Rank
S$661.89 B
Marketcap
$143.43
Share price
-1.86%
Change (1 day)
4.65%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total assets

Total assets on the balance sheet as of September 2024 : S$79.76 Billion

According to Novo Nordisk's latest financial reports the company's total assets are S$79.76 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novo Nordisk - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31S$61.51 B32.07%
2022-12-31S$46.57 B16.34%
2021-12-31S$40.03 B26.33%
2020-12-31S$31.69 B24.81%
2019-12-31S$25.39 B9.51%
2018-12-31S$23.18 B5.05%
2017-12-31S$22.06 B10.42%
2016-12-31S$19.98 B5.04%
2015-12-31S$19.02 B14.42%
2014-12-31S$16.63 B0.8%
2013-12-31S$16.49 B15.87%
2012-12-31S$14.23 B-2.44%
2011-12-31S$14.59 B3.41%
2010-12-31S$14.11 B-4.66%
2009-12-31S$14.80 B8.68%
2008-12-31S$13.62 B1.21%
2007-12-31S$13.45 B10.76%
2006-12-31S$12.15 B10.03%
2005-12-31S$11.04 B-1.34%
2004-12-31S$11.19 B12.96%
2003-12-31S$9.91 B26.3%
2002-12-31S$7.84 B2.26%
2001-12-31S$7.67 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
S$294.03 B 268.63%๐Ÿ‡บ๐Ÿ‡ธ USA
S$101.29 B 26.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$125.49 B 57.33%๐Ÿ‡บ๐Ÿ‡ธ USA
S$186.34 B 133.62%๐Ÿ‡ซ๐Ÿ‡ท France